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The search engine PubMed was used. Search
criteria included terms such as traumatic brain
injury, epidemiology, post-traumatic epilepsy, mild




biomarkers. Information from the
gliosis, and  
Centers for
Disease Control and Prevention and the American
Association of Neurological Surgeons was also
examined. Results were narrowed down to include
literature from the years 2015-2021 and relevant
literature from peer-reviewed journals was
evaluated.
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According to the Centers for Disease Control and
Prevention (2020), traumatic brain injury (TBI) is
considered a major public health problem in the
United States. Each year, 2.53 million Americans,
including 812,000 children, document a TBI-related
emergency room visit (1). TBI is a disruption in the
brain’s normal function, caused by a bump or blow to
the head or by penetrating head injury (1). These
injuries range in severity and can cause damage to
one area of the brain, as in focal injuries, or multiple
areas of the brain, as in diffuse injury (2).
Secondary processes related to TBI can result in
both temporary and long-term neurological
disabilities, including post-traumatic epilepsy (PTE),
a recurrent seizure disorder secondary to trauma to
the brain (6, 7). While the exact relationship between
TBI and PTE has not been identified, various
pathophysiological processes have been suggested.
Furthermore, there are currently no definitive tests to
evaluate TBI patients to determine the neurological
conditions that may arise. Research suggests the
utilization of biomarkers associated with neurological
damage as a means of diagnosing patients
presenting with head trauma. It is also suggested
that these biomarkers may give insight into the
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The time period after TBI, in which secondary injury processes
are initiated, is critical in the development of epilepsy and research
has shown that inflammatory molecules, including pro- inflammatory
cytokines like IL-1β and TNF - ⍺, may initiate early seizures (7). In the
nervous system, astrocytes regulate neuronal synapses, and during
neurotrauma, they protect uninjured tissue by a process termed
reactive gliosis (8). The elimination of a population of reactive
astrocytes leads to increased neurodegeneration and BBB deficits,
suggesting the neuroprotective effects of gliosis (8). Gliosis can also
lead to an overproduction of inflammatory cytokines and a
hyperexcited environment conducive to seizure development (7).
Given the challenges and cost burden of screening for TBI and
epilepsy, recent research has focused on the potential use of
biomarkers to diagnose injury and predict patients at risk of
developing PTE (9). Common biomarkers between TBI and PTE
include GFAP, IL-1, HMGB-1, UCH-L1, tau, and S100B (3). While
each marker can be associated with the processes underlying TBI,
more research is needed to establish relationships with
epileptogenesis.
Mechanisms of PTE (7,13)
TBI Inflammation PTE
Often resistant to anti-epileptic
drugs, it is vital to identify mechanisms
associated with PTE and ways to
prevent and treat its development (7).
Future studies should also take the
pediatric population into consideration,
as the 
pediatric
structural differences of the  
brain may alter the
given to the interaction of
processes involved (10).
Consideration should also be
TBI,
epilepsy, and COVID-19. Early studies
have connected the SARS-CoV-2
virus, neuroinflammation, and epilepsy
(11,12). Further information is needed
regarding the mechanisms of SARS-
CoV-2-induced epilepsy, especially in
patients presenting with TBI. With an
increased risk of PTE under normal
circumstances, TBI patients may be
particularly vulnerable to neurologic
dysfunction if infected with COVID-19.
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To conclude, there are many factors to consider when exploring the 
relationship between TBI and PTE. Diagnostic and prognostic
biomarkers may offer insight into secondary injury processes and
provide a preventative advantage. The interplay of several
neuropathophysiological processes related to neuroinflammation may
contribute to PTE. Further research should seek to establish causal
relationships and identify targets for therapeutic intervention.
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